Neuronal nicotinic acetylcholine receptor alpha-3 beta-2 subtype (α3β2 nAChR) (α3β2 nAChR)

The neuronal nicotinic acetylcholine receptor α3β2 subtype is a pentameric ligand-gated ion channel composed of α3 and β2 subunits. While the α3 subunit is traditionally associated with the peripheral nervous system in combination with β4, the α3β2 subtype is notably expressed in the central nervous system, particularly in hippocampal interneurons and the spinal cord [1, 3, 18]. In the hippocampus, it plays a crucial role in regulating the synchronous firing of pyramidal cells, making it a potential target for cognitive enhancers in conditions like Alzheimer's disease and ADHD [1, 3]. In the spinal cord, α3β2 receptors tonically inhibit the transmission of nociceptive mechanical stimuli, suggesting a role in pain modulation [18]. The receptor is activated by endogenous acetylcholine and exogenous nicotine, and it can be selectively blocked by toxins such as α-conotoxin MII [9, 18]. A significant challenge in targeting this receptor is achieving selectivity over the closely related α3β4 subtype to avoid systemic autonomic side effects like cardiovascular and gastrointestinal distress [1, 6]. Chronic nicotine exposure is known to upregulate the expression of α3β2 receptors, a process linked to the mechanisms of nicotine addiction [15]. Research into stoichiometry-specific subtypes of α3β2 suggests that different subunit ratios may offer even more precise therapeutic targets for neurological disorders [1, 3].

Other names

Alpha-3 beta-2 nicotinic receptorCHRNA3/CHRNB2 receptorNicotinic acetylcholine receptor alpha-3 beta-2 subtypeα3β2* nAChRNeuronal nicotinic acetylcholine receptor alpha-3 beta-2

Ligand-gated ion channel that opens upon binding of acetylcholine or nicotine, allowing the influx of cations (Na+, Ca2+) and efflux of K+, leading to membrane depolarization and modulation of neurotransmitter release.